Xywav Titration from 2.25 g Twice Nightly
Increase the total nightly dose by 1.5 g per week (0.75 g to each dose), targeting a therapeutic range of 6-9 g per night total. 1
Specific Titration Schedule
Starting from your current dose of 2.25 g twice nightly (4.5 g total):
- Week 1-2: 2.25 g at bedtime + 2.25 g (2.5-4 hours later) = 4.5 g total (current dose)
- Week 3: Increase to 3 g at bedtime + 3 g (2.5-4 hours later) = 6 g total
- Week 4: Increase to 3.75 g at bedtime + 3.75 g (2.5-4 hours later) = 7.5 g total
- Week 5: Increase to 4.5 g at bedtime + 4.5 g (2.5-4 hours later) = 9 g total (maximum)
The FDA label specifies that doses higher than 9 g per night have not been studied and should not be administered 1.
Key Titration Principles
Titrate based on efficacy and tolerability. Some patients achieve optimal responses at 6 g per night, while others require 7.5 g or 9 g. Monitor for:
- Efficacy markers: Reduction in excessive daytime sleepiness, improvement in cataplexy frequency (if present), better sleep quality
- Tolerability issues: Nausea (most common), dizziness, headache, vomiting 2, 3, 4
Unequal Dosing Option
Consider unequal nightly doses if standard equal dosing doesn't optimize symptom control. 1 The FDA label explicitly notes that some patients achieve better responses with unequal doses at bedtime versus 2.5-4 hours later. For example, a patient on 7.5 g total might benefit from 4 g at bedtime and 3.5 g for the second dose, or vice versa, depending on when symptoms are most problematic.
Critical Administration Requirements
- Administer at least 2 hours after eating to ensure proper absorption 1
- Second dose timing: Must be taken 2.5-4 hours after the first dose
- Patient must remain in bed after each dose due to CNS depression risk 1
Monitoring During Titration
Assess weekly during up-titration for:
- CNS depression signs: Excessive sedation, respiratory depression, confusion (particularly concerning given the black box warning) 1
- Common adverse effects: Nausea (22%), headache (18%), dizziness (12%) based on clinical trial data 3
- Cardiovascular parameters: Blood pressure if patient has cardiovascular risk factors
- Symptom improvement: Use validated scales like Epworth Sleepiness Scale to track objective improvement
Common Pitfalls to Avoid
Do not titrate faster than 1.5 g per week. Rapid titration increases risk of intolerable side effects, particularly nausea and dizziness, leading to treatment discontinuation 1.
Do not exceed 9 g total nightly dose. This is the maximum studied dose with established safety data 1.
Do not allow patients to take doses without adequate time in bed afterward. The risk of CNS depression and falls is substantial, particularly with the second dose when patients may be tempted to get up 1.